Verition Fund Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-3,901
| Closed | -$1.18M | – | 2377 |
|
|
2025
Q4 | $1.18M | Sell |
3,901
-2,454
| -39% | -$766K | 0.01% | 2028 |
|
|
2025
Q3 | $1.78M | Buy |
6,355
+2,313
| +57% | +$629K | 0.01% | 2075 |
|
|
2025
Q2 | $975K | Buy |
4,042
+247
| +7% | +$58.4K | 0.01% | 2493 |
|
|
2025
Q1 | $924K | Buy |
3,795
+2,403
| +173% | +$723K | 0.01% | 2183 |
|
|
2024
Q4 | $457K | Sell |
1,392
-2,078
| -60% | -$705K | ﹤0.01% | 2536 |
|
|
2024
Q3 | $1.16M | Buy |
3,470
+2,287
| +193% | +$726K | 0.01% | 1785 |
|
|
2024
Q2 | $323K | Sell |
1,183
-1,055
| -47% | -$307K | ﹤0.01% | 2297 |
|
|
2024
Q1 | $774K | Buy |
2,238
+509
| +29% | +$167K | 0.01% | 1759 |
|
|
2023
Q4 | $558K | Buy |
1,729
+603
| +54% | +$189K | 0.01% | 1467 |
|
|
2023
Q3 | $404K | Buy |
+1,126
| New | +$434K | 0.01% | 1560 |
|
|
2022
Q4 | – | Sell |
-2,124
| Closed | -$886K | – | 2172 |
|
|
2022
Q3 | $886K | Buy |
2,124
+1,233
| +138% | +$615K | 0.01% | 1488 |
|
|
2022
Q2 | $441K | Sell |
891
-375
| -30% | -$195K | 0.01% | 1513 |
|
|
2022
Q1 | $713K | Buy |
1,266
+255
| +25% | +$154K | 0.01% | 1693 |
|
|
2021
Q4 | $764K | Buy |
+1,011
| New | +$757K | 0.01% | 1461 |
|
|
2021
Q2 | – | Sell |
-467
| Closed | -$267K | – | 1884 |
|
|
2021
Q1 | $267K | Buy |
+467
| New | +$277K | ﹤0.01% | 1174 |
|
|
2020
Q4 | – | Sell |
-2,136
| Closed | -$1.1M | – | 1113 |
|
|
2020
Q3 | $1.1M | Buy |
2,136
+1,086
| +103% | +$550K | 0.04% | 359 |
|
|
2020
Q2 | $474K | Buy |
+1,050
| New | +$463K | 0.02% | 632 |
|
|
2020
Q1 | – | Sell |
-1,259
| Closed | -$466K | – | 633 |
|
|
2019
Q4 | $466K | Sell |
1,259
-850
| -40% | -$300K | 0.01% | 693 |
|
|
2019
Q3 | $702K | Sell |
2,109
-64
| -3% | -$20.9K | 0.04% | 509 |
|
|
2019
Q2 | $679K | Buy |
+2,173
| New | +$651K | 0.03% | 563 |
|
|
2019
Q1 | – | Sell |
-3,321
| Closed | -$771K | – | 1097 |
|
|
2018
Q4 | $771K | Buy |
3,321
+1,604
| +93% | +$430K | 0.06% | 317 |
|
|
2018
Q3 | $537K | Sell |
1,717
-5,670
| -77% | -$1.76M | 0.02% | 814 |
|
|
2018
Q2 | $2.13M | Buy |
7,387
+2,422
| +49% | +$669K | 0.14% | 182 |
|
|
2018
Q1 | $1.24M | Buy |
4,965
+1,075
| +28% | +$274K | 0.1% | 291 |
|
|
2017
Q4 | $928K | Buy |
3,890
+1,628
| +72% | +$394K | 0.1% | 267 |
|
|
2017
Q3 | $503K | Buy |
2,262
+326
| +17% | +$73.4K | 0.05% | 573 |
|
|
2017
Q2 | $438K | Sell |
1,936
-264
| -12% | -$57.5K | 0.05% | 490 |
|
|
2017
Q1 | $439K | Buy |
+2,200
| New | +$424K | 0.05% | 637 |
|
|
2016
Q2 | – | Sell |
-2,329
| Closed | -$318K | – | 883 |
|
|
2016
Q1 | $318K | Sell |
2,329
-530
| -19% | -$69.6K | 0.06% | 455 |
|
|
2015
Q4 | $396K | Buy |
+2,859
| New | +$396K | 0.08% | 240 |
|
|
2015
Q1 | – | Sell |
-8,011
| Closed | -$966K | – | 394 |
|
|
2014
Q4 | $966K | Buy |
8,011
+1,062
| +15% | +$122K | 0.26% | 50 |
|
|
2014
Q3 | $788K | Buy |
6,949
+116
| +2% | +$13.7K | 0.15% | 145 |
|
|
2014
Q2 | $818K | Buy |
+6,833
| New | +$834K | 0.14% | 146 |
|
|
2013
Q4 | – | Sell |
-23,105
| Closed | -$2.72M | – | 511 |
|
|
2013
Q3 | $2.72M | Buy |
23,105
+17,123
| +286% | +$2.02M | 0.55% | 50 |
|
|
2013
Q2 | $671K | Buy |
+5,982
| New | +$702K | 0.15% | 160 |
|
Other funds holding BIO
VCM
VPM
AI
